While the relative contribution of these putative R273C-p53 functions to the observed enhanced survival of R273C-p53 expressing cells in vitro and in vivo has yet to be fully discerned, these findings clearly demonstrate that mutant p53 proteins differentially impact tumor outcomes. The gene discussed is TP53; the disease is neoplasm.